Literature DB >> 8395128

Protection of swine against foot-and-mouth disease with viral capsid proteins expressed in heterologous systems.

M J Grubman1, S A Lewis, D O Morgan.   

Abstract

Three groups of swine were each inoculated with a different antigen preparation of foot-and-mouth disease virus (FMDV) capsid proteins and challenged by contact exposure to animals infected with FMDV. One group of four animals was inoculated with an extract from cells infected with a recombinant baculovirus containing the FMDV P1-2A structural protein precursor gene and a portion of the P2 gene. Two out of four animals were protected from clinical disease, but not from virus replication. A second group of animals was inoculated with an extract from Escherichia coli that expressed FMDV proteins from a construct containing the P1-2A gene, a portion of the P2 gene and the 3C protease gene. Three out of four animals in this group did not develop clinical signs of FMD upon challenge and two of four were protected against virus replication. In contrast, inoculation of a third group of swine with an extract from E. coli expressing the same FMDV construct as present in the recombinant baculovirus failed to protect any of the four animals from generalized FMD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395128     DOI: 10.1016/0264-410x(93)90357-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Nucleotide sequence of the P1 region of foot-and-mouth disease virus strain O1 Caseros.

Authors:  C Tami; G Kaplan; M E Piccone; E L Palma
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.

Authors:  J Chinsangaram; C Beard; P W Mason; M K Zellner; G Ward; M J Grubman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Comparison of immune responses against FMD by a DNA vaccine encoding the FMDV/O/IRN/2007 VP1 gene and the conventional inactivated vaccine in an animal model.

Authors:  Farahnaz Motamedi Sedeh; Hoorieh Soleimanjahi; AmirReza Jalilian; Homayoon Mahravani
Journal:  Virol Sin       Date:  2012-09-21       Impact factor: 4.327

5.  Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization.

Authors:  J C Sáiz; J Cairó; M Medina; D Zuidema; C Abrams; G J Belsham; E Domingo; J M Vlak
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.

Authors:  Gisselle N Medina; Nestor Montiel; Fayna Diaz-San Segundo; Diego Sturza; Elizabeth Ramirez-Medina; Marvin J Grubman; Teresa de los Santos
Journal:  Clin Vaccine Immunol       Date:  2015-11-25

7.  Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.

Authors:  Li Pan; Zhongwang Zhang; Jianliang Lv; Peng Zhou; Wenfa Hu; Yuzhen Fang; Haotai Chen; Xinsheng Liu; Junjun Shao; Furong Zhao; Yaozhong Ding; Tong Lin; Huiyun Chang; Jie Zhang; Yongguang Zhang; Yonglu Wang
Journal:  Int J Nanomedicine       Date:  2014-12-02

Review 8.  Vaccines for viral and parasitic diseases produced with baculovirus vectors.

Authors:  Monique M van Oers
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

9.  Production of foot-and-mouth disease virus SAT2 VP1 protein.

Authors:  Mpho Victoria Mamabolo; Jacques Theron; Francois Maree; Michael Crampton
Journal:  AMB Express       Date:  2020-01-07       Impact factor: 3.298

10.  Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine.

Authors:  Zhiyong Li; Yongzhu Yi; Xiangping Yin; Zhifang Zhang; Jixing Liu
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.